EICHORCondition: Postoperative Pain · Sponsor: Heron Therapeutics
This is a Phase 3, randomized, double-blind, saline placebo- and active-controlled, multicenter study to evaluate the analgesic efficacy and safety of HTX 011 administered via local administration into the surgical site in subjects undergoing bunionectomy.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Springhill Medical Center | Mobile, Alabama, United States | — |
| Orthopaedic Specialists of North America, PLLC | Mesa, Arizona, United States | — |
| Arizona Research Center | Phoenix, Arizona, United States | — |
| Anaheim Clinical Trials, LLC | Anaheim, California, United States | — |
| Trovare Clinical Research, Inc. | Bakersfield, California, United States | — |
| Alliance Research Centers | Laguna Hills, California, United States | — |
| Chesapeake Research Group, LLC | Pasadena, Maryland, United States | — |
| Optimal Research , LLC | Austin, Texas, United States | — |
| Hermann Drive Surgical Hospital | Houston, Texas, United States | — |
| Westside Surgical Hospital | Houston, Texas, United States | — |
| Futuro Clinical Trials, LLC | McAllen, Texas, United States | — |
| Plano Surgical Hospital | Plano, Texas, United States | — |
+ 3 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03295721